Aa
As expected
http://www.medpagetoday.com/MeetingCoverage/AdditionalMeetings/24389
At this point, they can't figure out which patients to treat. They won't really be able to test whether this treatment is better than a placebo until they can figure out who to treat and then split that group up for a designed double blinded sham controlled clinical study.
At this point, almost all of the data is anecdotal. There is no way to weed out the "wishful thinkers" from those that might be actually helped. There is also a problem that in several of the people that have been treated, the effect seems temporary.
It still may hold promise, but it is too early to tell. More research money needs to be spent.
Bob
At this point, almost all of the data is anecdotal. There is no way to weed out the "wishful thinkers" from those that might be actually helped. There is also a problem that in several of the people that have been treated, the effect seems temporary.
It still may hold promise, but it is too early to tell. More research money needs to be spent.
Bob
Wow...I barely understood any of that. Is it basically saying they aren't any closer to finding links between MS and vascular problems?
You are reading content posted in the Multiple Sclerosis Community
Top Neurology Answerers
Australia
ON
Queensland, Australia
Queen Creek, AZ
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease
